Answer
Naratriptan activates serotonin 5-HT1 receptors that constrict cranial blood vessels, and experimental evidence suggests it inhibits trigeminal nerve activity; both actions may contribute to migraine relief.
Sources for this answer
- Naratriptan 2.5 mg film coated tabletsMorningside Healthcare Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked